Pfizer profit soars in first quarter, revises 2022 forecast
COVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations as its profit grew 61%.
COVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations as its profit grew 61%.